Ventricular Pace Suppression Study

2010-07-15 17:00:00 | BioPortfolio


Investigation of the efficacy and safety of the Ventricular Pace Suppression (VpS) algorithm.


The aim of this study is to investigate the percentage of reduction of ventricular pacing using the VpS feature of the EVIA/ENTOVIS pacemaker in a controlled clinical investigation.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care


Pacemaker Indication


VpS algorithm in EVIA and ENTOVIS pacemakers


Klinikum Coburg gGmbH




Biotronik SE & Co. KG

Results (where available)

View Results


Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [441 Associated Clinical Trials listed on BioPortfolio]

Evia/Entovis HF-T Master Study

The Evia HF-T and the Entovis HF-T are triple-chamber pacemakers for cardiac resynchronisation therapy (CRT-P). The objective of this study is to prove the safety and efficacy of these pac...

Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker

The objective of this study is to prove the safety and efficacy of the EVIA pacemaker. Primarily, the newly implemented Atrial Capture Control algorithm is evaluated, which automatically m...

Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication

The aim of this study is to assess the benefits from the AAISafeR/SafeR algorithm of Symphony 2550 or REPLY DR in a wide range of pacemaker patients. The expected benefits will be a resul...

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

The purpose of this study is to collect data from pacemakers and determine how this information is used by physicians to care for their patients with pacemakers.

Morbidity, Mortality and Gender Differences in Patients With Pacemakers

Previous publications suggest gender difference in outcome parameters after pacemaker implantation. Aim of this study is to investigate gender differences in patients with pacemaker. Impla...

PubMed Articles [2602 Associated PubMed Articles listed on BioPortfolio]

In-vivo compatibility between pacemakers and dental equipment.

In-vitro studies suggest that electromagnetic interference can occur under specific conditions involving proximity between electronic dental equipment and pacemakers. At present, in-vivo investigation...

New Innovative Pacemaker Kevices - Leadless Pacemaker, Subcutaneous ICD.

Conventional transvenous pacemaker and ICD-therapy is associated with significant lead- and pocket-related problems. Leadless pacemaker and subcutaneous ICD (S-ICD) therapies are innovative technologi...

Troubleshooting in Patients with Implanted Pacemaker and ICD.

Because of the growing number of implanted cardiac pacemakers and defibrillators and the ever-increasing complexity of these devices a fundamental knowledge of device malfunctions is of utmost importa...

Guideline-Based Indications on Pacing and ICD-Therapy.

In 2016, there were 77 293 pacemakers and 28 953 ICDs implanted in Germany. This makes pacemaker- and ICD-implantations part of the most frequently performed operations in Germany. This article ad...

Utility of transthoracic impedance and novel algorithm for sleep apnea screening in pacemaker patient.

Pacing patients was revealed with a high prevalence of sleep disorder, but mostly undiagnosed. The pacemaker with transthoracic impedance sensor and novel algorithm could identify sleep apnea (SA) eve...

Medical and Biotech [MESH] Definitions

Tomography using x-ray transmission and a computer algorithm to reconstruct the image.

Regulation of the rate of contraction of the heart muscles by an artificial pacemaker.

Devices used for measuring physical activity as an indication of HEALTH STATUS.

A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external).

A rare cutaneous tumor of eccrine sweat gland origin. It is most commonly found on the extremities and is usually benign. There is no indication that heredity or external agents cause these tumors.

More From BioPortfolio on "Ventricular Pace Suppression Study"

Quick Search


Searches Linking to this Trial